心肌血管重建治療的發展及現今臨床實務

The Development and Current Clinical Practice of Myocardial Revascularization

10.6314/JIMT.201802_29(1).02

蔡劭謙(Sou-Chan Tsai)；王志鴻(Ji-Hung Wang)

心肌血管重建(Myocardial revascularization) ； 經皮冠狀動脈介入治療(Percutaneous coronary intervention, PCI) ； 冠狀動脈繞道手術(Coronary artery bypass grafting, CABG)

內科學誌

29卷1期（2018 / 02 / 01）

8 - 14

繁體中文

心肌血管重建治療目前主要是以心導管經皮冠狀動脈介入治療或者外科冠狀動脈繞道手術來治療因冠狀動脈狹窄而造成的心肌缺氧。而冠狀動脈疾病又可分為穩定型冠狀動脈疾病、ST段上升急性心肌梗塞及非ST段上升之急性冠心症。本文將介紹心肌血管重建治療的歷史演進及在不同類型的冠狀動脈疾病，心肌血管重建治療的適應症及其益處。

Myocardial revascularization is to treat myocardial ischemia caused by coronary artery stenosis and achieved mainly by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) nowadays. The coronary artery disease can be classified into stable coronary artery disease (SCAD), ST-segment elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome (NSTE-ACS). This article will introduce the historic development of myocardial revascularization, the indication and benefit of myocardial revascularization for different spectrums of coronary artery diseases.